Electroconvulsive therapy - Anaesthetic management;ELEKTROKRAMPFTHERAPIE - ANASTHESIOLOGISCHES VORGEHEN

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 32, Issue 10, 1997, Pages 593-603

  Mollenberg O ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Electroconvulsive therapy; Hypnotics; Major depression; Muscle relaxants

Indexed keywords

ESMOLOL; ETOMIDATE; HYPNOTIC AGENT; LITHIUM; METHOHEXITAL; MUSCLE RELAXANT AGENT; PROPOFOL; THIOPENTAL;

DEPRESSION; DEVICE; ELECTROCONVULSIVE THERAPY; GERMANY; HUMAN; MENTAL DISEASE; NEUROMUSCULAR BLOCKING; REVIEW; DRUG INTERACTION; GENERAL ANESTHESIA; METHODOLOGY; PATIENT CARE; TREATMENT OUTCOME;

ANESTHESIA, GENERAL; DEPRESSIVE DISORDER; DRUG INTERACTIONS; ELECTROCONVULSIVE THERAPY; HUMANS; PATIENT CARE TEAM; TREATMENT OUTCOME;

EID: 0030856348     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995114     Document Type: Review

References (91)

1. Abrams R: Seizure generalization and unilateral electroconvulsive therapy. Convuls. Ther. 1991;7:213-217
2. Agnew WF, Yuen TGH, McCreery DB: Morphologic changes after prolonged electrical stimulation of the cat's cortex at defined charge densities. Exp. Neurol. 1983;79:397-411
3. American Psychiatric Association, Task Force for ECT: The practice of ECT: Recommendations for treatment, training, and privileging. Convuls. Ther. 1990;2:85-120
4. American Psychiatric Association: Practice guidelines for the treatment of patients with bipolar disorder. Am. J. Psychiatry 1994;151:Supplement
5. Avramov MN, Husain MM, White PF: The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth. Anaig. 1995;81:596-602
6. Ayd FJ: Methohexital (Brevital): A new anesthetic for electroconvulsant therapy. Diseas Nerv. Syst. 1961;22:383-390
7. Bennett AE: Curare: A preventive of traumatic complications in convulsive shock therapy. Nachgedruckt in Am. J. Psychiatry 1994;151(Suppl.):249-258
8. Berigan TR, Harazin J, Williams HL: Use of flumazenil in conjunction with electroconvulsive therapy. Am. J. Psychiatry 1995;152:957
9. Bolwig TG, Hertz MM, Paulson O, Spotoft H, Refaelsen OJ: The permeability of the blood-brain barrier during electrically induced seizures in man. Eur. J. Clin. Invest. 1977;7:87-93
10. Bready LL, Tyler DS: Electroconvulsive therapy. In: Albin MS (ed.): Textbook of neuroanesthesia with neurosurgical and neuroscience perspectives. 1st ed. McGraw-Hill, New York, 1997: 707-734
11. Brodersen P, Paulson OB, Bolwig TG, Rogon ZF, Rafaelsen OJ, Lassen NA: Cerebral hyperemia in electrically induced epileptic seizures. Arch. Neurol. 1973;23:334-338
12. Burnstein RM, Denny N: Mivacurium in electroconvulsive therapy. Anesthesia 1993;48:1116
13. Caroff SN, Rosenberg H, Fletcher JE, Heiman-Patterson TD, Mann SC: Malignant hyperthermia susceptibility in neuroleptic malignant syndrome. Anesthesiology 1987;67:20-25
14. Castelli I, Steiner LA, Kaufmann MA, Alfillé PH, Schouten R, Welch CA, Drop LJ: Comparative effects of esmolol and labetanolol to attenuate hyperdynamic states after electroconvulsive therapy. Anesth. Analg. 1995;80:557-561
15. Crider BA, Hansen-Grant S: Nonconvulsive status epilepticus as a cause for delayed emergence after electroconvulsive therapy. Anesthesiology 1995;82:591-593
16. Crow TJ, Johnstone EC: Controlled trials of electroconvulsive therapy. Ann. NY. Acd. Sci. 1986;462:12-29
17. Decina P, Malitz S, Sackeim HA, Holzer J, Yudofsky S: Cardiac arrest during ECT modified by betaadrenergic blockade. Am. J. Psychiatry 1984;14:298-300
18. Devanand DP, Dwork AJ, Hutchinson ER, Bolwig TG, Sackeim HA: Does ETC alter brain structure? Am. J. Psychiatry 1994;151: 957-970
19. Douyon R, et al.: ECT and Parkinson's disease revisited: A naturalistic study. Am. J. Psychiatry 1989;146:1451-1455
20. Dwyer R, McCaughey W, Lavery J, McGarthy G, Dundee JW: Comparison of propofol and methohexitone as anesthetic agents for electroconvulsive therapy. Anaesthesia 1988;43:459-462
21. El-Ganzouri AR, Ivankovich AD, Braverman B, McCarthy R: Monoamine oxidase inhibitors: Should they be discontinued preoperatively? Anesth. Analg. 1985;64:592-596
22. Fink M: How does convulsive therapy work? Neuropsychopharmacology 1990;3:73-82
23. Fragen RJ, Avram MJ: Nonopioid intravenous anesthetics. In: Barash PG, Cullen BF, Stoelting RK (eds.): Clinical anesthesia. 1st ed. Lippincott-Raven, Philadelphia, New York 1989:227-253
24. Fredman B, d'Etienne J, Smith I, Husain MM, White PF: Anesthesia for electroconvulsive therapy: Effects of propofol and methohexital on seizure activity and recovery. Anesth. Analg. 1994;79:75-79
25. Folkerts H: Elektrokrampftherapie. Dt. Ärztebl. 1995;92:A-358-364
26. Gaines GY, Rees I: Electroconvulsive therapy and anesthetic considerations. Anesth. Analg. 1986;65:1345-1356
27. Gillies BS, Lecky JH: Anesthesia for nonoperative locations. In: Barash PG, Cullen BF, Stoelting RK (eds.): Clinical anesthesia. 3rd ed. Lippincott-Raven, Philadelphia, New York 1996;1237-1247
28. Gitlin MC, Jahr JS, Margolis MA, McCain J: Is mivacurium chloride effective in electroconvulsive therapy? A report of four cases, including a patient with myasthenia gravis. Anesth. Analg. 1993;77:392-394
29. Hoffman BB, Lefkowitz PJ: Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Goodman Gilman A, Limbird LE: Goodman & Gilman's The Pharmacological basis of therapeutics. 9th ed. McGraw-Hill, New York 1995:199-248
30. Hood DD, Mecca RS: Failure to initiate electroconvulsive seizures in a patient pretreated with lidocain. Anesthesiology 1983;58: 379-381
31. Howie MB, Black HA, Zvara DA, McSweeney TD, Martin DJ, Coffman JA: Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy. Anesth. Analg. 1990;71:384-388
32. Howie MB, Hiestand DC, Zvara DA, Kim PY, McSweeney TD, Coffman JA: Defining the dose range for esmolol used in electroconvulsive therapy hemodynamic attenuation. Anesth. Analg. 1992;75:805-810
33. Ilvicky H, Caroff SN, Simone AF: Etomidate during ECT for elderly seizure-resistant patients. Am. J. Psychiatry 1995;152:957-958
34. Janicak PG, Davis JM, Gibbons RD, Ericksen S, Chang S, Gallagher P: Efficiacy of ECT: a meta-analysis. Am. J. Psychiatry 1985;142: 297-302
35. Jelen-Esselborn S: Trizyklische Antidepressiva sollten präoperativ abgesetzt werden: Kontra. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 1995;30:249-251
36. Kalinowski LB: History of convulsive therapy ECT. Ann. NY Acad. Sci. 1986;462:1-4
37. Kellner CH, Nixon DW, Bernstein HJ: ECT-drug interactions: A review. Psychopharmacol. Bull. 1991;27:595-609
38. Konarzewski WH, Milosavljevic D, Robinson M, Braham W, Beales F: Sucamethonium dosage in electroconvulsive therapy. Anesthesia 1988;43:474-476
39. Lawson NW, Meyer DJ: Autonomic nervous system: Physiology and pharmacology. In: Barash PG, Cullen BF, Stoelting RK (eds.): Clinical anesthesia, 3rd ed. Lippincott-Raven, Philadelphia, New York 1996:243-309
40. Laughlin TP, Newberg LA: Prolonged myoclonus after etomidate anesthesia. Anesth. Analg. 1985;64:80-82
41. Lunn RJ, Savageau MM, Beatty WW, Gerst JW, Staton RD, Brumback RA: Anesthetics and electroconvulsive therapy seizure duration: implications for therapy from a rat model. Biol. Psychiatry 1981;16:1163-1175
42. Malsch E, Gratz I, Mani S, Backup C, Levy S, Allen E: Efficiacy of electroconvulsive therapy after propofol and methohexital anesthesia. Convuls. Ther. 1994;10:212-219
43. Martensson B, Bartfai A, Hallén B, Hellström C, Junthé T, Olander M: A comparison of propofol ane methohexital as anesthetic agents for ECT: Effects on seizure duration, therapeutic outcome, and memory. Biol. Psychiatry 1994;35:179-189
44. Maneksha FR: Hypertension and tachykardia during electroconvulsive therapy: To treat or not to treat? Convuls. Ther. 1991;7: 28-35
45. Matters RM, Beckett WG, Kirkby KC, King TE: Recovery after electroconvulsive therapy: comparison of propofol with methohexitone anaesthesia. Br. J. Anaesth. 1995;75:297-300
46. McCleave DJ, Blakemore WB: Anaesthesia for electroconvulsive therapy. Anaesth. Intens. Care 1975;3:250-256
47. Mclnnes EJ, James NM: A comparison of ketamine and methohexital in electroconvulsive therapy. Med. J. Aust. 1972;1:1031-1032
48. McNamara JO: Drugs effective in the therapy of the epilepsies. In: Hardman JG, Goodman Gilman A, Limbird LE: Goodman & Gilman's The Pharmacological basis of therapeutics. 9th ed. McGraw-Hill, New York 1995:461-486
49. Meistelmann C, Plaud B, Donati F: Neuromuscular effects of succinylcholine on the vocal chords and adductor pollicis muscles. Anesth. Analg. 1991;73:278-282
50. Modica PA, Templehoff R, White PF: Pro- and anticonvulsant effects of anesthetics (Part II). Anesth. Analg. 1990;70:433-444
51. Mokriski BK, Nagle SE, Papuchis GC, Cohen SM, Waxman GJ: Electroconvulsive therapy-induced cardiac arrhythmias during anesthesia with methohexital, thiamylal, or thiopental sodium. J. Clin. Anesth. 1992;4:208-212
52. Moyers JR: Preoperative medication. In: Barash PG, Cullen BF, Stoelting RK (eds.): Clinical anesthesia. 3rd ed. Lippincott-Raven, Philadelphia, New York 1996:519-533
53. Mukherjee S, Sackeim HA, Lee C: Unilateral ECT in the treatment of manic episodes. Convulsive Therapy 1988;4:74-80
54. Mukherjee S: Combined ECT and lithium therapy. Convuls. Ther. 1993;9:274-284
55. Mukherjee S, Sackeim HA, Schnur DB: Electroconvulsive therapy of acute manic episodes: A review of 50 years' experience. Am. J. Psychiatry 1994;151:169-176
56. National Institutes of Health: Consensus conference: Electroconvulsive therapy. JAMA 1985;254:2103-2108
57. Nettelbladt P: Factors influencing number of treatments and seizure duration in ECT: Drug treatment, social class. Convuls. Ther. 1988;4:160-168
58. Diesen AC, Lolk A, Christensen P: Effect of a single nighttime dose of oxazepam on seizure duration in electroconvulsive therapy. Convuls. Ther. 1989;5:3-7
59. Pace NL: Prevention of succinylcholine myalgias: A meta-analysis. Anesth. Analg. 1990;70:477-483
60. Petrides G, Fink M: Atrial fibrillation, anticoagulation, and electroconvulsive therapy. Convuls. Ther. 1996;12:91-98
61. Pitts FN, Gilles MD, Stewart W, Schaberg K: Induction of anesthesia with methohexital and thiopental in electroconvulsive therapy. N. Eng. J. Med. 1965;273:353-360
62. Posner JB, Phum F, Van Poznak A: Cerebral metabolism during electrically induced seizures in man. Arch. Neurol. 1969;20: 388-395
63. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, Greenberg R, Rifas SL, Sackeim HA: Resistance to antidepressant medications and short-term clinical response to ECT. Am. J. Psychiatry 1996;153:985-992
64. Rampton AJ, Griffin RM, Stuart CS, Durcan JJ, Huddy NC, Abbott MA: Comparison of methohexital and propofol for electroconvulsive therapy: Effects on hemodynamic responses and seizure duration. Anesthesiology 1989;70:412-417
65. Reddy RV, Moorthy SS, Dierdorf SF: Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol. Anesth. Analg. 1993;77:1008-1011
66. Rice EH, Sombrotto LB, Markowitz JC, Leon AC: Cardiovascular morbidity in high-risk patients during ECT. Am. J. Psychiatry 1994;151:1637-1641
67. Rouse EC: Propofol for electroconvulsive therapy. A comparison with methohexitone. Preliminary report. Anesthesia 1988; 43(suppl.):61-64
68. Sackeim HA, Decina P, Prohovnik I, Malitz S: Seizure threshold in electroconvulsive therapy. Effects of sex, age, electrode placement, and number of treatments. Arch. Gen. Psychiatry 1987;44:355-360
69. Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fritzsimons L, Moody J, McElhiney MC, Coleman EA, Settembrino JM: Effects of stimulus intensity and electrode placement on the efficiacy and cognitive effects of electroconvulsive therapy. N. Eng. J. Med. 1993;328:839-846
70. Sackeim HA, Long J, Luber B, Moeller JR, Prohovnik I, Devanand DP, Nobler MS: Physical properties and quantification of the ECT stimulus: I. Basic principles. Conv. Ther. 1994;10:93-123
71. Sackeim HA: Physical properties of the ECT stimulus. Convuls. Ther. 1994;10:140-152
72. Saito S, Yoshikawa D, Nishihara F, Morita T, Kitani Y, Amaya T, Fujita T: The cerebral hemodynamic response to electrically induced seizures in man. Brain Res. 1995;673:93-100
73. Scott Al: Contemporary practice of electroconvulsive therapy. Br. J. Hosp. Med. 1994;51:334-338
74. Selvin BL: Electroconvulsive therapy - 1987. Anesthesiology 1987;67:367-385
75. Simpson KH, Halsall PJ, Carr CME, Stewart KG: Propofol reduces seizure duration in patients having anesthesia for electroconvulsive therapy. Br. J. Anesth. 1988;61:343-344
76. Sobin C, Prudic J, Devanand DP, Nobler MS, Sackeim HA: Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment. Br. J. Psychiatry 1996; 169:322-328
77. Sonntag H: intravenöse Hypnotika und Anästhetika. In: Doenikke A, Kettler W, List W, Radke J, Tarnow J (Hrsg.): Anästhesiologie. 7. Aufl. Springer, Berlin, Heidelberg, New York 1995:55-92
78. Spiss CK, Smith CM, Maze M: Halothane-epinehrine arrhythmias and adrenergic responsiveness after chronic imipramine administration in dogs. Anesth. Analg. 1984;63:825-828
79. Squire LR, Chace PM: Memory functions six to nine month after electroconvulsive therapy. Arch. Gen. Psychiatry 1975;32:1557-1564 nachgedruckt in Convuls. Ther. 1997;12:239-256
80. Squire LR, Chace PM: Memory functions six to nine month after electroconvulsive therapy. Arch. Gen. Psychiatry 1975;32:1557-1564 nachgedruckt in Convuls. Ther. 1997;12:239-256
81. Stack CG, Rogers P, Linter SPK: Monoamine oxidase inhibitors and anesthesia. Br. J. Anesth. 1988;60:222-227
82. Swartz CM: Propofol anesthesia in ECT. Convuls. Ther. 1992;8: 262-266
83. Taeger K: Wirkungen und Nebenwirkungen von Injektionsnarkotika. In: Peter K, Frey L, Hobbhahn J (Hrsg.): Anästhesiologie. I. Aufl. Enke, Stuttgart 1989:28-38
84. Wauquier A: Profile of etomidate. Anesthesia 1983;38(suppl.): 26-33
85. Weeks D, Freeman CP, Kendell RE: ECT: III. Enduring cognitive deficits? Br. J. Psychiatry 1980;137:26-37
86. Weinger MB, Partridge BL, Hauger R, Mirow A: Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. Effectiveness of pretreatment regimens on hemodynamics. Anesth. Analg. 1991;73:556-562
87. Weinger MB, Partridge BL, Hauger R, Mirow A: Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: II. Effects of pretreatment regimens on catecholamines, ACTH, vasopressin, and Cortisol. Anesth. Analg. 1991;73: 563-569
88. Welch CA, Drop LJ: Cardiovacular effects of ECT. Convuls. Ther. 1989;5:35-43
89. Wulfson HD, Askanazi J, Finck AD: Propranolol prior to ECT associated with asystole. Anesthesiology 1984;60:255-256
90. Wyant GM, MacDonald WB: The role of atropine in electroconvulsive therapy. Anesth. Intens. Care 1980;8:445-450
91. Zielinski RJ, Roose SP, Devanand DP, Woodring S, Sackeim HA: Cardiovascular complications of ECT in depressed patients with cardiac disease. Am. J. Psychiatry 1993;150:904-909